In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Arena Pharmaceuticals Inc (NASDAQ:ARNA) reported that Great Point Partners has picked up 30,000,000 of common stock as of 2017-04-28. The acquisition brings the aggregate amount owned by Great Point Partners to a total of 30,000,000 representing...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC),Incyte Corp (NASDAQ:INCY) reported that Baker Bros. Advisors has picked up 34,295,011 of common stock as of 2017-04-28. The acquisition brings the aggregate amount owned by Baker Bros. Advisors to a total of 34,295,011 representing less...
CytRx Corporation (NASDAQ:CYTR) shares were down 15.02% on Thursday to $0.685 and an additional 7.65% in after-hours trading to $0.632. The company has a market cap of $75.70 million at 117.32 million shares outstanding. Share prices have been trading in a 52-week range of $0.36 to $3.46. CytRx Corporation is a...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Ptc Therapeutics Inc. (NASDAQ:PTCT) reported that Complete Pharma Holdings Ii, Llc. has picked up 6,683,598 of common stock as of 2017-04-27. The acquisition brings the aggregate amount owned by Complete Pharma Holdings Ii, Llc. to a...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Oncomed Pharmaceuticals Inc (NASDAQ:OMED) reported that Biotechnology Value Fund L P has picked up 1,372,923 of common stock as of 2017-04-27. The acquisition brings the aggregate amount owned byBiotechnology Value Fund L P to a total...